The drug is naturally eliminated from the body, so it is unlikely to accumulate or create new problems for people with kidney ...

The FDA has granted Priority Review to pegcetacoplan for the treatment of C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.

Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of worsening kidney disease in people with type 2 diabetes. The approval ...

[Also read: Diabetes at 30? Habits putting young Indians at risk, 5 prevention tips for millennials and Gen Z in India] In an interview with HT Lifestyle, Dr Rajiv Kovil, Head of Diabetology at ...